Implus named Official Military Sponsor for the Durham Bulls
Footwear accessories supplier Implus on Monday partnered with the Durham Bulls as the Official Military Sponsor for the 2018 baseball season. The partnership provides free home game tickets for active duty military for Durham Bulls regular season games at Durham Bulls Athletic Park.
“[Our company] is proud to continue bringing our country’s heroes and their families together,” Todd Vore, president Implus, said. “The Durham Bulls have been a great local partner, along with producing some great baseball. We are happy to thank the brave women and men for their service, and hope they enjoy this season.”
The free admission program has been sponsored by the foot device manufacturer, which operates out of Durham, N.C., since 2011.
In addition to free home game admission tickets, the company will also sponsor the Salute Our Troops PA announcement at select games, recognizing and thanking each military branch for their sacrifices and service. Having veterans and those who have served in the military be a part of the Implus workforce coupled with some of the largest military bases in their communities, the military sponsorship has been important to Implus for years.
New WebMD Symptom Checker empowers self care
WebMD on Thursday launched a new version of its iconic WebMD Symptom Checker. The tool, introduced in 2005, has been completely redesigned with an emphasis on providing a better user experience and more accurate results.
“The WebMD Symptom Checker is our flagship tool that consumers turn to each month for information on their health concerns,” Steven L. Zatz, CEO WebMD, said. “Our redesign reflects our commitment to continually improving the experience of consumers when seeking answers to their health questions. We take very seriously our role in the consumer healthcare experience, and we have enhanced the tool to deliver the most accurate results possible.”
More than 75 million people visit WebMD every month for the latest health information, news and trends, and millions of them use WebMD’s Symptom Checker to research symptoms and learn about possible conditions so they are better informed and more confident about what to do next.
The new WebMD Symptom Checker features a revamped user interface designed to provide consumers with a simple and seamless experience powered by a professional-grade diagnostic engine used by physicians to support their point-of-care decisions. WebMD has made this possible by mapping clinical symptomology and diagnoses into easy-to-understand language that will be accessible to millions of users. The new Symptom Checker features three times more symptoms and potential conditions than the previous version.
It is anticipated that these changes will resonate with millions of users.
Additionally, WebMD has evolved the interface so that visitors can simply type in how and what they are feeling, rather than trying to connect specific areas of the body to specific ailments – a process that consumers indicated was a challenge when their symptoms were generalized, for example, in the case of body aches, chills or fever.
Once a user has typed in their symptoms and other relevant information, including medical history and medications, the Symptom Checker generates a list of potential conditions that are ordered and rated based on the strength of the correlation between the particular condition and the information provided by the user. The tool is integrated with WebMD’s Physician Directory to help WebMD visitors find the care they need to address their health issues.
The Symptom Checker was redesigned based on feedback from WebMD users, medical experts, and leading academics and researchers. Additionally, a major impetus for the redesign was a 2015 article in the British Medical Journal about a study evaluating the accuracy of several symptom checker tools. WebMD has attempted to address issues raised in the BMJ article to provide consumers with an accurate and useful symptom checker experience.
“Providing accurate, trustworthy medical information is our core mission,” Michael Smith, medical director WebMD, said. “We are confident that this completely redesigned Symptom Checker will empower users with even more personalized and helpful information than ever before, while making it easy for them to connect with a health care professional to get the medical care they need.”
Perrigo launches own brand-exclusive innovation in new PPI
Perrigo and its partner Dexcel Pharma Technologies on Thursday launched a store brand Omeprazole Delayed Release Orally Disintegrating Tablets 20mg (Omeprazole ODT) that features MelTech melt-in-your-mouth technology, which dissolves in the mouth without water.
“Consumers want a heartburn medication that provides effective, long-term relief, but they also want a product that is easy and convenient to take,” Jeff Needham, executive vice president and president, Consumer Healthcare Americas, Perrigo, said. “Our novel Omeprazole ODT product combines the effective heartburn relief of omeprazole with innovative MelTech melt-in-your-mouth technology that heartburn sufferers desire. Perrigo is excited to be the first to bring this innovation to the heartburn OTC category while still delivering quality, affordable store-brand products to consumers.”
According to IRI, retail sales of omeprazole (as an active ingredient) totaled more than $600 million for the last 12 months, when combining store brand and the nationally advertised brand, Prilosec OTC.
Store brand omeprazole is more cost-effective than national heartburn brand solutions, with customers saving an average of 20% to 30% when purchasing store brand. Omeprazole ODT treats the same frequent heartburn symptoms as name brand products that use omeprazole as the active ingredient.
Omeprazole ODT is a proton pump inhibitor that works by blocking the production of acid in the stomach, which often leads to heartburn. PPIs are FDA-approved for patients 18 years of age and older. Omeprazole is the number one selling active ingredient in PPIs. One 20mg tablet should be taken daily for 14 days to relieve frequent heartburn symptoms. Unless instructed by your doctor, Omeprazole ODT should not be taken for more than 14 days, and at least four months should pass before beginning another treatment regimen.
Heartburn is considered frequent when symptoms are experienced at least two times per week. According to the American College of Gastroenterology, more than 15 million Americans experience heartburn symptoms each day. More than eight in 10 adults face some type of gastrointestinal problem, and more than half (57 percent) seek out treatments with an over-the-counter medication. Additionally, 52 percent turn to medical professionals, friends or family members for help in deciding how to treat digestive health issues.